BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-06-24
- Last Posted Date
- 2022-04-28
- Lead Sponsor
- Bayer
- Target Recruit Count
- 22153
- Registration Number
- NCT04444804
- Locations
- 🇩🇪
Multiple facilities, Multiple Locations, Germany
A Study Using the LMC Diabetes Registry to Learn More About Chronic Kidney Disease (CKD) in Canadian Patients With Type 2 Diabetes (T2D)
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-06-24
- Last Posted Date
- 2021-10-05
- Lead Sponsor
- Bayer
- Target Recruit Count
- 14873
- Registration Number
- NCT04445181
- Locations
- 🇨🇦
A Database, A Database, Canada
Clinical Study on the Effect of Elevit Pregnancy 2nd & 3rd Trimester (Multi-micronutrients & DHA Supplement) on the Nutritional Status of Pregnant Women During Second and Third Trimester
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-06-19
- Last Posted Date
- 2020-11-16
- Lead Sponsor
- Bayer
- Target Recruit Count
- 164
- Registration Number
- NCT04438928
- Locations
- 🇮🇹
ASST Fatebenefratelli Sacco, Milano, Lombardia, Italy
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
- First Posted Date
- 2020-06-17
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Bayer
- Target Recruit Count
- 6016
- Registration Number
- NCT04435626
- Locations
- 🇺🇸
Eastern Shore Research Institute, LLC | Fairhope, AL, Fairhope, Alabama, United States
🇺🇸Mobile Heart Specialists, PC, Mobile, Alabama, United States
🇺🇸Heart Clinic Arkansas, Little Rock, Arkansas, United States
Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1011
- Registration Number
- NCT04423718
- Locations
- 🇧🇬
SEHAT Pentagram, Sofia, Bulgaria
🇧🇬University Multiprofile Hospital For Active Treatment 'Alexandrovska' EAD, Sofia, Bulgaria
🇺🇸Arizona Retina and Vitreous Consultants - North Phoenix, Phoenix, Arizona, United States
Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by an Electrocardiogram in Healthy Male and Female Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2022-01-24
- Lead Sponsor
- Bayer
- Target Recruit Count
- 42
- Registration Number
- NCT04423744
- Locations
- 🇩🇪
CRS Clinical Research Services Mannheim GmbH, Mannheim, Baden-Württemberg, Germany
This Study Collects Information on the Safety of Inhaled Pegylated Adrenomedullin (PEG-ADM), How the Drug is Tolerated and How it Affects Patients Suffering From a Type of Lung Failure That Cause Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Bayer
- Target Recruit Count
- 90
- Registration Number
- NCT04417036
- Locations
- 🇪🇸
Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain
🇪🇸Hospital de la Santa Creu i de Sant Pau, Barcelona, Spain
🇨🇿Fakultni nemocnice v Motole, Praha 5, Czechia
A Study to Collect Data on the Treatment Pattern of Xarelto + Acetylsalicylic Acid in the Routine Clinical Practice in Patients Who Are Suffering From a Condition That Narrows the Blood Vessels Supplying the Heart and / or a Condition That Most Commonly Narrows the Blood Vessel in the Legs
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-05-26
- Last Posted Date
- 2023-10-25
- Lead Sponsor
- Bayer
- Target Recruit Count
- 3189
- Registration Number
- NCT04401761
- Locations
- 🇨🇳
Many Locations, Multiple Locations, Taiwan
Study to Learn More About Outcomes Reported by Patients Suffering From Type 2 Diabetes Using a Digital Data Collection Tool
- First Posted Date
- 2020-05-11
- Last Posted Date
- 2021-07-01
- Lead Sponsor
- Bayer
- Target Recruit Count
- 32
- Registration Number
- NCT04383041
- Locations
- 🇩🇪
Many locations, Multiple Locations, Germany
Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Impaired Liver Function and Healthy Participants Matched for Age-, Gender-, and Weight
- First Posted Date
- 2020-04-29
- Last Posted Date
- 2020-04-29
- Lead Sponsor
- Bayer
- Target Recruit Count
- 32
- Registration Number
- NCT04366622
© Copyright 2024. All Rights Reserved by MedPath